期刊文献+

紫外分光光度法测定萘哌地尔片中萘哌地尔的含量

Content Determination of Naftopidil in Naftopidil Tablets by Ultraviolet Spectrophotometry
下载PDF
导出
摘要 采用紫外分光光度法测定萘哌地尔片中萘哌地尔含量。以无水乙醇为溶剂,在283nm波长处测定溶液的吸光度,计算萘哌地尔的含量。萘哌地尔在9.96-49.80μg/mL浓度范围内与吸收度呈良好线性关系(r=0.9995),低、中、高三个浓度的平均回收率分别为98.84%、100.49%、99.37%,RSD分别为0.25%、0.12%、0.35%。该方法操作简单,灵敏度高,结果准确,重现性好,可用于萘哌地尔片中萘哌地尔的质量控制。 A method for the content determination of Naftopidil in Naftopidil Tablets by ultraviolet spectrophotometry was established. The determination was performed on the ultraviolet spectrophotometry after the Naftopidil extracted by absolute alcohol. The content of Naftopidil was calculated in determination absorbance of the solution at 283 nm wavelength. Naftopidil Tablets had good linear relationship between Abs and concentration of ethacridine ( r = 0. 9995 ) ranging from 9.96 -49.80 μg/mL, with an average recovery rate of 98.84% , 100. 49%, 99.37% , RSD was 0. 25%, 0. 12%, 0. 35%. The method was simple to operate, had high sensitivity, system accuracy and good repeatability, and could be used in the quality control of Naftopidil in Naftopidil Tablets.
作者 刘欣
出处 《广州化工》 CAS 2016年第19期146-147,185,共3页 GuangZhou Chemical Industry
关键词 萘哌地尔 紫外分光光度法 测定 Naftopidil ultraviolet spectrophotometry determination
  • 相关文献

参考文献5

二级参考文献49

  • 1梁秀山.良性前列腺增生症的治疗现状[J].中国医药导报,2010,7(23):12-14. 被引量:17
  • 2刘玉强,徐祗顺,史本康,王传运.萘哌地尔片治疗良性前列腺增生症的临床研究[J].山东大学学报(医学版),2005,43(12):1170-1172. 被引量:4
  • 3[1]Peter G,Niebch G,Locher M,et al.Pharmacokinetic fate of the novel antihypertensive drug naftopidil[J].Arzneimittelforschun g,1991,41(9)∶924-93 1.
  • 4[2]Niebch G,Locher M,Borbe HO.Metabolic fate of the novel antihypert ensive drug naftopidil[J].Arzneimittelforschung,1991,41(10)∶1027-1032.
  • 5[3]Borbe HO,Peter G.Radioreceptor assay for the determination of alp ha1-adr enoceptor-binding material in rat plasma following single oral administration o f naftopidil[J].Arzneimittelforschung,1990,40(3)∶253-256.
  • 6[4]Niebch G, Borbe HO,Besenfelder E.High-performance liquid chromat ography of naftopidil,a novel antihypertensive drug, and two metabolites in human plasm a[J].J Chromatogr,1990,534∶247-252.
  • 7[5]Terakado T,Oki E,Iida M,et al.Metabolism of naftopidil (KT-6 11) in healthy volunteers[J].J Clin Ther Med,1992,8(Suppl 3)∶S3-S9.
  • 8[6]NN.Naftopidil:Investigational Drug Brochure[R].ASTA Medica AG,1 992.
  • 9[7]Takagi N,Ishii M,Takeda K,et al.Pharmacokinetics of naftopidi l (KT-6 11) in hypertensive patients with renal impairment or normal renal function[J] .J Clin Ther Med,1992,8(Suppl 3)∶S109-S122.
  • 10[8]Farthing MJ,Alstead EM,Abrams SM,et al.Pharmacokinetics of na ftopidil ,a novel anti-hypertensive drug,in patients with hepatic dysfunction[J].Pos tgrad Med J,1994,70(823)∶363-366.

共引文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部